<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe 3 patients who presented to the emergency department (ED) with <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:hpo ids='HP_0002625'>deep venous thrombosis</z:hpo>, or <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> and <z:hpo ids='HP_0000083'>renal failure</z:hpo> after undergoing cardiac surgery 7 to 17 days earlier </plain></SENT>
<SENT sid="1" pm="."><plain>Their <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0005048'>thrombosis</z:mp> after previous <z:chebi fb="5" ids="28304">heparin</z:chebi> exposure was temporally plausible for complications of <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo>, an immune-mediated thrombotic disorder triggered by <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The patients had <z:mpath ids='MPATH_458'>normal</z:mpath> platelet counts at presentation, yet each had circulating <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo> antibodies that were ultimately confirmed </plain></SENT>
<SENT sid="3" pm="."><plain>Two patients had <z:chebi fb="5" ids="28304">heparin</z:chebi> reexposure in the ED, 1 of whom developed <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> with new <z:mp ids='MP_0005048'>thrombosis</z:mp> and died </plain></SENT>
<SENT sid="4" pm="."><plain>Alternative parenteral anticoagulation prevented further <z:mp ids='MP_0005048'>thrombosis</z:mp> in 2 patients </plain></SENT>
<SENT sid="5" pm="."><plain>Because <z:chebi fb="5" ids="28304">heparin</z:chebi> use can be catastrophic in patients with <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo>, physicians should be vigilant in suspecting <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo> in patients with <z:mp ids='MP_0005048'>thrombosis</z:mp> after recent hospitalization or <z:chebi fb="5" ids="28304">heparin</z:chebi> exposure </plain></SENT>
<SENT sid="6" pm="."><plain>Alternative <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> are available for these at-risk patients </plain></SENT>
</text></document>